Supplementary Table S2 from Caffeine Supplementation and FOXM1 Inhibition Enhance the Antitumor Effect of Statins in Neuroblastoma

Supplementary Table S2 from Caffeine Supplementation and FOXM1 Inhibition Enhance the Antitumor Effect of Statins in Neuroblastoma

<p>Simvastatin responsive genes</p>

Kaydedildi:

Detaylı Bibliyografya
Yazar:	Gia-Buu Tran (16437051) (author)
Diğer Yazarlar:	Jane Ding (16437054) (author), Bingwei Ye (16437057) (author), Mengling Liu (16437060) (author), Yajie Yu (16437063) (author), Yunhong Zha (16437066) (author), Zheng Dong (16437069) (author), Kebin Liu (14939874) (author), Sunil Sudarshan (16437072) (author), Han-Fei Ding (16437075) (author)
Baskı/Yayın Bilgisi:	2025
Konular:	Cancer Molecular and Cellular Biology Therapeutic Research and Development Drug Targets Metabolism Metabolic pathways Pediatric Cancers Small Molecule Agents
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller

Table S3 from Caffeine Supplementation and FOXM1 Inhibition Enhance the Antitumor Effect of Statins in Neuroblastoma
Yazar:: Gia-Buu Tran (16437051)
Baskı/Yayın Bilgisi: (2025)

Table S4 from Caffeine Supplementation and FOXM1 Inhibition Enhance the Antitumor Effect of Statins in Neuroblastoma
Yazar:: Gia-Buu Tran (16437051)
Baskı/Yayın Bilgisi: (2025)

Table S5 from Caffeine Supplementation and FOXM1 Inhibition Enhance the Antitumor Effect of Statins in Neuroblastoma
Yazar:: Gia-Buu Tran (16437051)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table S1 from Caffeine Supplementation and FOXM1 Inhibition Enhance the Antitumor Effect of Statins in Neuroblastoma
Yazar:: Gia-Buu Tran (16437051)
Baskı/Yayın Bilgisi: (2025)

Supplemental Table 1 from Mitochondrial Uncoupling Induces Epigenome Remodeling and Promotes Differentiation in Neuroblastoma
Yazar:: Haowen Jiang (14963613)
Baskı/Yayın Bilgisi: (2025)

Supplemental Table 2 from Mitochondrial Uncoupling Induces Epigenome Remodeling and Promotes Differentiation in Neuroblastoma
Yazar:: Haowen Jiang (14963613)
Baskı/Yayın Bilgisi: (2025)

Supplemental Table 3 from Mitochondrial Uncoupling Induces Epigenome Remodeling and Promotes Differentiation in Neuroblastoma
Yazar:: Haowen Jiang (14963613)
Baskı/Yayın Bilgisi: (2025)

Supplemental Table 4 from Mitochondrial Uncoupling Induces Epigenome Remodeling and Promotes Differentiation in Neuroblastoma
Yazar:: Haowen Jiang (14963613)
Baskı/Yayın Bilgisi: (2025)

Table S1 from Intracellular Acetyl CoA Potentiates the Therapeutic Efficacy of Antitumor CD8<sup>+</sup> T Cells
Yazar:: Snehanshu Chowdhury (14957031)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table S2 from Metabolomic, DNA Methylomic, and Transcriptomic Profiling of Suberoylanilide Hydroxamic Acid Effects on LPS-Exposed Lung Epithelial Cells
Yazar:: Pochung Jordan Chou (14851578)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table S3 from Metabolomic, DNA Methylomic, and Transcriptomic Profiling of Suberoylanilide Hydroxamic Acid Effects on LPS-Exposed Lung Epithelial Cells
Yazar:: Pochung Jordan Chou (14851578)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table S4 from Metabolomic, DNA Methylomic, and Transcriptomic Profiling of Suberoylanilide Hydroxamic Acid Effects on LPS-Exposed Lung Epithelial Cells
Yazar:: Pochung Jordan Chou (14851578)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table 1 from Impact of Frontline Ivosidenib on Volumetric Growth Patterns in Isocitrate Dehydrogenase–mutant Astrocytic and Oligodendroglial Tumors
Yazar:: David Olayinka Kamson (16617218)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table 2 from Impact of Frontline Ivosidenib on Volumetric Growth Patterns in Isocitrate Dehydrogenase–mutant Astrocytic and Oligodendroglial Tumors
Yazar:: David Olayinka Kamson (16617218)
Baskı/Yayın Bilgisi: (2025)

Effects of <i>T. gondii</i> infection on rat gut microbiota diversity.
Yazar:: Ji-Xin Zhao (22056386)
Baskı/Yayın Bilgisi: (2025)

Supplementary Data File 1 from Phase II Investigation of TVB-2640 (Denifanstat) with Bevacizumab in Patients with First Relapse High-Grade Astrocytoma
Yazar:: William Kelly (15439117)
Baskı/Yayın Bilgisi: (2025)

Supplementary Data File 2 from Phase II Investigation of TVB-2640 (Denifanstat) with Bevacizumab in Patients with First Relapse High-Grade Astrocytoma
Yazar:: William Kelly (15439117)
Baskı/Yayın Bilgisi: (2025)

Table S1 from CD36 Drives Metastasis and Relapse in Acute Myeloid Leukemia
Yazar:: Thomas Farge (15112135)
Baskı/Yayın Bilgisi: (2025)

Table S2 from CD36 Drives Metastasis and Relapse in Acute Myeloid Leukemia
Yazar:: Thomas Farge (15112135)
Baskı/Yayın Bilgisi: (2025)

Table S3 from CD36 Drives Metastasis and Relapse in Acute Myeloid Leukemia
Yazar:: Thomas Farge (15112135)
Baskı/Yayın Bilgisi: (2025)

Table S4 from CD36 Drives Metastasis and Relapse in Acute Myeloid Leukemia
Yazar:: Thomas Farge (15112135)
Baskı/Yayın Bilgisi: (2025)

Supplementary Data from ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline Glioma
Yazar:: Evangeline R. Jackson (15558808)
Baskı/Yayın Bilgisi: (2025)

Figure S1 from The Oncolytic Adenovirus XVir-N-31 Joins Forces with CDK4/6 Inhibition Augmenting Innate and Adaptive Antitumor Immunity in Ewing Sarcoma
Yazar:: Sebastian Johannes Schober (14971891)
Baskı/Yayın Bilgisi: (2025)

Figure S2 from The Oncolytic Adenovirus XVir-N-31 Joins Forces with CDK4/6 Inhibition Augmenting Innate and Adaptive Antitumor Immunity in Ewing Sarcoma
Yazar:: Sebastian Johannes Schober (14971891)
Baskı/Yayın Bilgisi: (2025)

Figure S3 from The Oncolytic Adenovirus XVir-N-31 Joins Forces with CDK4/6 Inhibition Augmenting Innate and Adaptive Antitumor Immunity in Ewing Sarcoma
Yazar:: Sebastian Johannes Schober (14971891)
Baskı/Yayın Bilgisi: (2025)

Figure S4 from The Oncolytic Adenovirus XVir-N-31 Joins Forces with CDK4/6 Inhibition Augmenting Innate and Adaptive Antitumor Immunity in Ewing Sarcoma
Yazar:: Sebastian Johannes Schober (14971891)
Baskı/Yayın Bilgisi: (2025)

Figure S5 from The Oncolytic Adenovirus XVir-N-31 Joins Forces with CDK4/6 Inhibition Augmenting Innate and Adaptive Antitumor Immunity in Ewing Sarcoma
Yazar:: Sebastian Johannes Schober (14971891)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table 1 from ANO1 Reprograms Cholesterol Metabolism and the Tumor Microenvironment to Promote Cancer Metastasis
Yazar:: Chun-Miao Deng (15618965)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table 2 from ANO1 Reprograms Cholesterol Metabolism and the Tumor Microenvironment to Promote Cancer Metastasis
Yazar:: Chun-Miao Deng (15618965)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table 3 from ANO1 Reprograms Cholesterol Metabolism and the Tumor Microenvironment to Promote Cancer Metastasis
Yazar:: Chun-Miao Deng (15618965)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table 4 from ANO1 Reprograms Cholesterol Metabolism and the Tumor Microenvironment to Promote Cancer Metastasis
Yazar:: Chun-Miao Deng (15618965)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table 6 from ANO1 Reprograms Cholesterol Metabolism and the Tumor Microenvironment to Promote Cancer Metastasis
Yazar:: Chun-Miao Deng (15618965)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table 7 from ANO1 Reprograms Cholesterol Metabolism and the Tumor Microenvironment to Promote Cancer Metastasis
Yazar:: Chun-Miao Deng (15618965)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table 8 from ANO1 Reprograms Cholesterol Metabolism and the Tumor Microenvironment to Promote Cancer Metastasis
Yazar:: Chun-Miao Deng (15618965)
Baskı/Yayın Bilgisi: (2025)

Supplementary Table 9 from ANO1 Reprograms Cholesterol Metabolism and the Tumor Microenvironment to Promote Cancer Metastasis
Yazar:: Chun-Miao Deng (15618965)
Baskı/Yayın Bilgisi: (2025)

Supplementary Data from Epithelial-to-Mesenchymal Transition Supports Ovarian Carcinosarcoma Tumorigenesis and Confers Sensitivity to Microtubule Targeting with Eribulin
Yazar:: Gwo Yaw Ho (14961416)
Baskı/Yayın Bilgisi: (2025)

Supplementary Video from Shortwave Infrared Imaging Enables High-Contrast Fluorescence-Guided Surgery in Neuroblastoma
Yazar:: Laura Privitera (16015972)
Baskı/Yayın Bilgisi: (2025)

Figure S1 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models
Yazar:: Elizabeth R. Tucker (15053624)
Baskı/Yayın Bilgisi: (2025)

Figure S2 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models
Yazar:: Elizabeth R. Tucker (15053624)
Baskı/Yayın Bilgisi: (2025)

Figure S3 from Combination Therapies Targeting ALK-aberrant Neuroblastoma in Preclinical Models
Yazar:: Elizabeth R. Tucker (15053624)
Baskı/Yayın Bilgisi: (2025)

Cannot write session to /tmp/vufind_sessions/sess_1uv6jsaaiadvtmelfkvtl1413f